NC
LMAT icon

nVerses Capital’s LeMaitre Vascular LMAT Stock Holding History

nVerses Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,889
Closed -$234K – 424
2025
Q4 		$234K Buy
+2,889
New +$249K 0.52% 108
2024
Q4 		– Sell
-700
Closed -$65K – 482
2024
Q3 		$65K Sell
700
-100
-13% -$8.66K 0.03% 573
2024
Q2 		$65.8K Buy
800
+200
+33% +$14.7K 0.04% 537
2024
Q1 		$39.8K Buy
+600
New +$37K 0.1% 314

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

nVerses Capital's LMAT Position: Q1 2026 in Review

nVerses Capital sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 2,889 shares — an estimated $234K sold.

nVerses Capital first reported a position in LMAT in Q1 2024 and held it in 4 quarters. The position peaked at $234K in Q4 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • nVerses Capital reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • nVerses Capital sold 2,889 LeMaitre Vascular shares in Q1 2026, an estimated $234K.
  • nVerses Capital first reported a position in LeMaitre Vascular in Q1 2024 and held it in 4 quarters.
  • nVerses Capital's LeMaitre Vascular position peaked at $234K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.